Al-Dawaa Medical Services closes four international branches to focus on Saudi market

SAUDI ARABIA—Al-Dawaa Medical Services Company is closing four of its international subsidiaries as part of a strategic shift to centralize all business activities within Saudi Arabia.

The prominent Saudi healthcare and retail pharmacy operator announced the decision on March 9, emphasizing its commitment to streamlining management structures and operational efficiency.

The company plans to bring all its business functions under the umbrella of its main Saudi entity.

This restructuring will eliminate the complexity of managing multiple international offices while concentrating resources and expertise in the Kingdom.

German and Dubai entities face closure

The Board of Directors has already set in motion the voluntary liquidation process for four overseas subsidiaries.

In Germany, the company will close both Hollinz GmbH and Ronzak GmbH.

Meanwhile, in Dubai, Al-Dawaa will wind down operations at Glanzzen FZ-LLC and Al-Dawaa Medical Services FZ-LLC.

The firm confirmed that these closures represent a deliberate strategic choice rather than a response to financial difficulties.

Management has carefully evaluated the benefits of consolidation against the advantages of maintaining an international footprint.

Financial impact deemed minimal

Al-Dawaa assured investors and stakeholders that the branch closures will not significantly affect the company’s financial position.

The healthcare provider emphasized that its operational cash flows will remain stable throughout the transition period.

This assessment suggests that the international operations represented a relatively small portion of the company’s overall business portfolio.

The closures appear designed to improve efficiency rather than cut costs in response to financial pressure.

Alignment with Saudi Vision 2030

The consolidation move fits squarely within Saudi Arabia’s ambitious Vision 2030 framework, which seeks to transform the Kingdom into a leading regional business center.

Al-Dawaa explicitly linked its decision to this national strategy, highlighting the government’s push to strengthen domestic business capabilities.

“This decision is in line with the company’s commitment to Saudi Vision 2030, which aims to strengthen the Kingdom’s leading regional position as a business hub, support the localisation of business activities and enhance local content within the Kingdom,” the firm stated.

The Vision 2030 initiative encourages Saudi companies to expand their domestic operations while building the country’s reputation as an attractive destination for regional and international business.

By localizing its activities, Al-Dawaa contributes to the broader goal of creating more opportunities within Saudi Arabia.

Supporting local content development

The move also supports the government’s localization agenda, which prioritizes developing local talent, increasing domestic production, and reducing dependence on foreign operations.

Al-Dawaa’s decision to concentrate its resources within Saudi Arabia reinforces these objectives while potentially creating additional employment opportunities for Saudi nationals.

The company now turns its attention to strengthening its position in the domestic healthcare and pharmacy market as it prepares to operate exclusively within the Kingdom.